$RFL News Article - Rafael Pharmaceuticals Announc
Post# of 24
(Total Views: 251)
Posted On: 07/01/2021 12:20:49 PM
$RFL News Article - Rafael Pharmaceuticals Announces Positive Preplanned Interim Futility Analysis of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/rafa...04810.html
(0)
(0)Rafael Holdings, Inc. (RFL) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼